Interstitial deletion of 7q22.1q31.1 in a boy with structural brain abnormality, cardiac defect, developmental delay,

Insights

A male child experienced feeding issues, hypotonia, and developmental delays due to a 7q22.1q31.1 deletion. This genetic finding highlights the impact of interstitial deletions on neurodevelopment and congenital anomalies.

Area of Science:

  • Genetics
  • Pediatrics
  • Developmental Biology

Background:

  • Genetic deletions on chromosome 7 can lead to complex developmental disorders.
  • Understanding the phenotypic spectrum of 7q deletions is crucial for diagnosis and management.

Observation:

  • A male infant presented with feeding difficulties, hypotonia, sensorineural hearing loss, cerebral cortical agenesis, cardiac defects, dysmorphic features, and developmental delays.
  • CytoScan HD array analysis revealed a 12.1 Mb interstitial deletion in the 7q22.1q31.1 region.

Findings:

  • The identified deletion encompasses a critical region associated with neurodevelopmental and congenital anomalies.
  • A literature review of overlapping 7q deletions was conducted to correlate genotype with phenotype.
  • Candidate genes within the deleted segment were analyzed for their potential role in the observed clinical features.

Implications:

  • This case expands the known phenotypic variability associated with intermediate 7q deletions.
  • Identification of candidate genes may provide insights into the molecular mechanisms underlying the observed abnormalities.
  • Accurate genetic diagnosis is essential for genetic counseling and clinical management of affected individuals.

Related Concept Videos

Karyotyping01:17

Karyotyping

Overview
69.8K
Meiosis I01:49

Meiosis I

Meiosis is a carefully orchestrated set of cell divisions, the goal of which—in humans—is to produce haploid sperm or eggs, each containing half the number of chromosomes present in somatic cells elsewhere in the body. Meiosis I is the first such division, and involves several key steps, among them: condensation of replicated chromosomes in diploid cells; the pairing of homologous chromosomes and their exchange of information; and finally, the separation of homologous chromosomes by...
221.5K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
652
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
38.6K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
26.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K